Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Campbell David Alan Create: Alert

All | News | Filings
Date FiledTypeDescription
01/05/2023 4 Campbell David Alan (CEO) has filed a Form 4 on Janux Therapeutics, Inc.
Txns: Granted 310,000 options to buy @ $14.02, valued at $4.3M
01/05/2022 4 Campbell David Alan (CEO) has filed a Form 4 on Janux Therapeutics, Inc.
Txns: Granted 354,250 options to buy @ $20.24, valued at $7.2M
06/10/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy